AK Medical Holdings Limited (1789.HK)

6,050 -0,130 (-2,10%) Börsenschluss: 04:08PM HKT

AK Medical Holdings Limited

Xingye Building
2nd Floor No. 10 Baifuquan Road Changping District Science & Tech Park
Beijing 102200
China
86 10 8010 9581
https://www.ak-medical.net

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 1.052

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Zhijiang Li	Chairman & CEO	1,05M	N/A	1968
Ms. Bin Mo Zhang	Senior VP & Executive Director	32,38k	N/A	1968
Mr. Chaoyang Zhang	Senior VP & Executive Director	1,17M	N/A	1969
Ms. Xiaohong Zhao	Executive Director	1,22M	N/A	1978
Ms. Kun Liang	Chief Financial Officer	N/A	N/A	1985
Mr. Hanzhong Sun	Vice President of Human Resources	N/A	N/A	1971
Ms. Yu Han	Company Secretary	N/A	N/A	1983

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in HKD.

Beschreibung

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, and customised products and services. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.

Corporate Governance

AK Medical Holdings Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.